OXA-23 mRNA Vaccine

N/A

Report date: 2026/04/07 11:11:40

Base Information

Drug NameOXA-23 mRNA Vaccine
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcinetobacter Baumannii Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImperial College LondonRQ Biotechnology LtdKymab Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKymab LtdImperial College LondonRQ Biotechnology Ltd
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A